Robert Iannone Insider Trading $JAZZ Jazz Pharmaceuticals plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Iannone.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Iannone. Robert Iannone is Chief Medical Officer in IMMUNOMEDICS INC ($IMMU) and EVP R&D, Chief Medical Officer in Jazz Pharmaceuticals plc ($JAZZ) and EVP, Research & Development in Jazz Pharmaceuticals plc ($JAZZ) and Director in Jounce Therapeutics, Inc. ($JNCE) and Director in iTeos Therapeutics, Inc. ($ITOS).
Robert Iannone in Jazz Pharmaceuticals plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Iannone: EVP R&D, Chief Medical Officer, EVP, Research & Development
Holdings: 30,145 shares
Current Value: $3,769,632
Latest Transaction: Mar 09 2021
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Robert Iannone in Jazz Pharmaceuticals plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IMMU, ITOS, JAZZ, JNCE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 09 2021 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP R&D, Chief Medi ... | Payment of Exercise | F | 164.75 | 741 | 122,080 | 30,145 | 30.9 K to 30.1 K (-2.40 %) |
| Jun 05 2020 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Payment of Exercise | F | 120.65 | 943 | 113,773 | 22,204 | 23.1 K to 22.2 K (-4.07 %) |
| Jun 05 2020 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Payment of Exercise | F | 120.65 | 943 | 113,773 | 22,204 | 23.1 K to 22.2 K (-4.07 %) |
| Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Option Exercise | A | 113.10 | 26,116 | 2,953,720 | 26,116 | |
| Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Option Exercise | A | 113.10 | 884 | 99,980 | 884 | |
| Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Grant | A | 0.00 | 10,800 | 0 | 23,000 | 12.2 K to 23 K (+88.52 %) |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Option Exercise | A | 137.12 | 27,584 | 3,782,318 | 27,584 | |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Option Exercise | A | 137.12 | 2,916 | 399,842 | 2,916 | |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Grant | A | 0.00 | 12,200 | 0 | 12,200 | 0 to 12.2 K |
Page: 1